Found 1 publication. Displayed publication 1
Expand all publications       Show all as text (SweetDB notation)

1. (Article ID: 5287)
 
Tohyama S, Takahashi Y, Akamatsu Y
Biosynthesis of amycolamicin: The biosynthetic origin of a branched α-aminoethyl moiety in the unusual sugar amycolose
The Journal of Antibiotics 63(3) (2010) 147-149
 

Amycolamicin is a new antibiotic, which has been isolated from the culture broth of Amycolatopsis sp. MK575-fF5 during our screening program for drug-resistant pathogens. Structurally, amycolamicin has unique features compared with other antibiotics; it contains trans-decalin, tetramic acid, two unusual sugars and pyrrole carbonic acid. Amycolamicin has bactericidal activity not only against a wide variety of bacteria but also against drug-resistant pathogens, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, which are major pathogenic bacterial causes of hospital infections. There is a strong need to develop novel antibiotics with unique structures and modes of action because pathogens resistant to the ‘last resort’ antibiotic vancomycin have emerged. Judging from the present situation, amycolamicin could be considered as a potential candidate antibiotic

antibiotic, amycolamicin, amycolose, Amycolatopsis sp. MK575-fF5

The publication contains the following compound(s):
 

Expand this publication

Resort publications by:

New query Export IDs Home Help

Execution: <1 sec